Clinical Trial Update: Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) [NA]

View source ↗

Summary

A completed clinical trial evaluating Macugen (pegaptanib) for its effects on surgical outcomes and VEGF levels in diabetic patients with proliferative diabetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Proliferative Diabetic Retinopathy, Diabetic Macular Edema | NA | Status: COMPLETED